Clinical Trial Update: Phase 2 Study of Sorafenib Plus HAIC of FOLFOX vs. Sorafenib Plus HAIC of OXA for Advanced HCC [Phase 2]

View source ↗

Summary

Phase 2 trial comparing sorafenib with hepatic arterial infusion chemotherapy (HAIC) using FOLFOX versus HAIC using oxaliplatin for advanced hepatocellular carc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• HAIC of FOLFOX
• HAIC of OXA
• Sorafenib (Sorafenib)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN